- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Automatic Translation feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
The association between type 1 and 2 diabetes mellitus and the risk of leukemia: a systematic review and meta-analysis of 18 cohort studies
-
- Yan Pengfei
- Department of Preventive Medicine, School of Health Sciences, Wuhan University, Wuhan 430071, China
-
- Wang Yongbo
- Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan 430071, China
-
- Fu Tao
- Department of Gastrointestinal Surgery II, Renmin Hospital, Wuhan University, Wuhan 430060, China
-
- Liu Yu
- Department of Statistics and Management, School of Management, Wuhan Institute of Technology, Wuhan 430205, China
-
- Zhang Zhi-Jiang
- Department of Preventive Medicine, School of Health Sciences, Wuhan University, Wuhan 430071, China
Search this article
Description
<p>Diabetes mellitus (DM) is widely considered to be associated with the risk of diverse cancers; however, the association between DM and the risk of leukemia is still controversial. Thus, a detailed meta-analysis of cohort studies was conducted to elucidate this association. Eligible studies were screened through the electronic searches in PubMed, Web of Science, and Embase from their inception to August 11, 2020. Summary relative risks (RRs) and 95% confidence intervals (CIs) were computed through the random-effects model. Eighteen articles involving 10,516 leukemia cases among a total of 4,094,235 diabetic patients were included in this meta-analysis. Overall, twenty-five RRs were synthesized for type 2 diabetes mellitus (T2DM) and yielded a summary RR of 1.33 (95%CI, 1.21–1.47; p < 0.001). For type 1 diabetes mellitus (T1DM), 7 RRs were combined, however, the pooled RR was insignificant (RR, 1.08; 95%CI, 0.87–1.34; p = 0.48). Interestingly, the summary RR for East Asia (RR, 1.83, 95%CI, 1.63–2.06) was significantly higher than that for Europe (RR, 1.11, 95%CI, 1.06–1.15), Western Asia (RR, 1.40, 95%CI, 1.25–1.54), North America (RR, 1.14, 95%CI, 1.08–1.20), and Australia (RR, 1.47, 95%CI, 1.25–1.71). Moreover, we found that patients with a shorter T2DM duration (1–5 years) had a higher risk of leukemia compared to those with a longer duration (5.1–10 years). Overall, this meta-analysis suggests there is a moderately increased risk of leukemia among T2DM patients, but not in T1DM patients. Further investigation is warranted.</p>
Journal
-
- Endocrine Journal
-
Endocrine Journal 68 (3), 281-289, 2021
The Japan Endocrine Society
